Soleno Therapeutics (SLNO) News Today $82.76 +1.19 (+1.46%) Closing price 04:00 PM EasternExtended Trading$82.97 +0.21 (+0.25%) As of 05:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock SLNO Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Soleno Therapeutics (NASDAQ:SLNO) Price Target Raised to $121.00 at Robert W. BairdJuly 14 at 2:31 AM | americanbankingnews.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) is Emerald Advisers LLC's 8th Largest PositionJuly 13 at 6:08 AM | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) is Emerald Mutual Fund Advisers Trust's 7th Largest PositionJuly 12 at 8:37 AM | marketbeat.comSoleno Therapeutics Shares Dip Following $200 Million Stock Offering PricingJuly 11 at 10:32 AM | msn.comSoleno Therapeutics (NASDAQ:SLNO) Stock Price Expected to Rise, Robert W. Baird Analyst SaysJuly 11 at 8:25 AM | marketbeat.comSoleno Therapeutics (NASDAQ:SLNO) Sees Unusually-High Trading Volume - Time to Buy?July 10, 2025 | marketbeat.comSoleno Therapeutics stock dips on proposed $200M offeringJuly 10, 2025 | msn.comSoleno Therapeutics Announces Pricing of $200 Million Public Offering of Common StockJuly 10, 2025 | globenewswire.comSoleno Therapeutics, Inc. Announces $200 Million Public Offering to Fund VYKAT XR Commercialization and R&D ActivitiesJuly 10, 2025 | quiverquant.comQSoleno Therapeutics Announces Proposed $200 Million Public Offering of Common StockJuly 10, 2025 | globenewswire.comSoleno Therapeutics Announces Preliminary Financial and Operational Results for the Second Quarter Ended June 30, 2025July 10, 2025 | globenewswire.comSoleno Therapeutics (NASDAQ:SLNO) Sets New 52-Week High - Time to Buy?July 9, 2025 | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Receives Average Recommendation of "Buy" from AnalystsJuly 9, 2025 | americanbankingnews.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Given Consensus Recommendation of "Buy" by BrokeragesJuly 9, 2025 | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Stock Holdings Lowered by Allspring Global Investments Holdings LLCJuly 6, 2025 | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Insider Sells $316,970.80 in StockJuly 4, 2025 | insidertrades.comOppenheimer & Co. Inc. Takes Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)July 4, 2025 | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Insider Patricia C. Hirano Sells 3,830 SharesJuly 3, 2025 | marketbeat.comSoleno Therapeutics Announces Two Presentations Featuring VYKAT(TM) XR in Prader-Willi Syndrome at ENDO 2025July 1, 2025 | finance.yahoo.comSoleno Therapeutics (NASDAQ:SLNO) Reaches New 1-Year High - What's Next?June 30, 2025 | marketbeat.comLisanti Capital Growth LLC Purchases Shares of 25,365 Soleno Therapeutics, Inc. (NASDAQ:SLNO)June 29, 2025 | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Insider Sells $22,410.50 in StockJune 26, 2025 | marketbeat.comSLNO Soleno Therapeutics, Inc. - Seeking AlphaJune 25, 2025 | seekingalpha.comSoleno gains as Betaville cites buyout interest (update)June 24, 2025 | msn.comSoleno Therapeutics (NASDAQ:SLNO) Sets New 1-Year High - Here's What HappenedJune 23, 2025 | marketbeat.comSoleno Therapeutics initiated with a Buy at TD CowenJune 23, 2025 | msn.comFDA Approval for its Drug Lifted Soleno Therapeutics (SLNO) Shares by 60%June 23, 2025 | msn.comSoleno Therapeutics (NASDAQ:SLNO) Coverage Initiated at TD CowenJune 23, 2025 | marketbeat.comSoleno Therapeutics: Overbought On VYKAT Approval EnthusiasmJune 22, 2025 | seekingalpha.comGAMMA Investing LLC Increases Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)June 22, 2025 | marketbeat.comPiper Sandler Reaffirms Overweight Rating on Soleno (SLNO) Driven by Strong VYKAT XR ProspectsJune 20, 2025 | msn.comSoleno Therapeutics to Present Research Findings at 2025 International Prader-Willi Syndrome ConferenceJune 20, 2025 | quiverquant.comQSoleno Therapeutics Announces Multiple Presentations at the 2025 United in Hope: International Prader-Willi Syndrome ConferenceJune 20, 2025 | globenewswire.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Receives Consensus Rating of "Buy" from BrokeragesJune 14, 2025 | marketbeat.com434,514 Shares in Soleno Therapeutics, Inc. (NASDAQ:SLNO) Acquired by Assenagon Asset Management S.A.June 13, 2025 | marketbeat.comSoleno Therapeutics (NASDAQ:SLNO) Sets New 12-Month High - Here's What HappenedJune 12, 2025 | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Shares Acquired by Harbor Capital Advisors Inc.June 11, 2025 | marketbeat.comCalifornia State Teachers Retirement System Has $988,000 Stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO)June 11, 2025 | marketbeat.comCantor Fitzgerald Comments on SLNO FY2026 EarningsJune 10, 2025 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 5,462 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO)June 10, 2025 | marketbeat.comNuveen Asset Management LLC Has $2.84 Million Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)June 3, 2025 | marketbeat.comWellington Management Group LLP Grows Stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO)June 1, 2025 | marketbeat.comAmeriprise Financial Inc. Increases Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)June 1, 2025 | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Shares Acquired by Polar Asset Management Partners Inc.May 28, 2025 | marketbeat.comQ2 EPS Estimate for Soleno Therapeutics Boosted by AnalystMay 27, 2025 | marketbeat.comToronto Dominion Bank Makes New $1.17 Million Investment in Soleno Therapeutics, Inc. (NASDAQ:SLNO)May 26, 2025 | marketbeat.comSoleno Therapeutics seeking regulatory approval in treatment of PWSMay 24, 2025 | finance.yahoo.comSoleno Therapeutics, Inc. (SLNO) Secures EMA Validation for PWS Treatment VYKAT XRMay 24, 2025 | finance.yahoo.comSoleno Therapeutics, Inc. (SLNO) Secures EMA Validation for PWS Treatment VYKAT XRMay 24, 2025 | finance.yahoo.comWoodline Partners LP Reduces Holdings in Soleno Therapeutics, Inc. (NASDAQ:SLNO)May 24, 2025 | marketbeat.com Get Soleno Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SLNO and its competitors with MarketBeat's FREE daily newsletter. Email Address SLNO Media Mentions By Week SLNO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SLNO News Sentiment▼0.911.01▲Average Medical News Sentiment SLNO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SLNO Articles This Week▼166▲SLNO Articles Average Week Get Soleno Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SLNO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Femasys News Immunovant News Solventum News Smith & Nephew SNATS News Penumbra News Stevanato Group News Glaukos News Bausch + Lomb News Inari Medical News iRhythm Technologies News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SLNO) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Soleno Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Soleno Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
